SCHEMBL29960164

SCHEMBL29960164

Cn1c(=O)n(C)c2cc(Nc3ccnc(Cl)c3C#N)ccc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ BCL6 P41182 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20568273 0.87 BCL6 (0.77) BCL6
SCHEMBL23388959 0.87 BCL6 (1.00) BCL6
SCHEMBL30745326 0.85 BCL6 (1.00) BCL6
SCHEMBL20569509 0.85 BCL6 (1.00) BCL6
SCHEMBL29960423 0.85 BCL6 (1.00) BCL6
SCHEMBL31357285 0.85 BCL6 (0.77) BCL6
SCHEMBL20568793 0.85 BCL6 (0.77) BCL6
SCHEMBL20569756 0.85 BCL6 (1.00) BCL6
SCHEMBL20569510 0.85 BCL6 (1.00) BCL6
SCHEMBL20569796 0.84 BCL6 (0.85) BCL6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3630291-B9 BENZIMIDAZOLONE DERIVED INHIBITORS OF BCL6 CANCER RESEARCH TECH LTD (GB) 2024-05-29 — — EP claimed
EP-3630291-B1 BENZIMIDAZOLONE DERIVED INHIBITORS OF BCL6 CANCER RESEARCH TECH LTD (GB) 2024-01-10 — — EP claimed
EP-4061834-A1 CHEMICALLY INDUCIBLE POLYPEPTIDE POLYMERIZATION Dana-Farber Cancer Institute, Inc. (US) 2022-09-28 — — EP claimed
EP-4061834-A1 CHEMICALLY INDUCIBLE POLYPEPTIDE POLYMERIZATION Dana-Farber Cancer Institute, Inc. (US) 2022-09-28 — — EP disclosed
Send feedback